Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
2000 1
2001 3
2002 2
2003 1
2004 1
2005 3
2006 7
2007 5
2008 1
2009 5
2010 4
2011 4
2012 3
2013 2
2014 3
2015 4
2016 1
2017 1
2018 2
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

53 results
Results by year
Filters applied: . Clear all
Page 1
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
Hardy J, Baggott C, Fingleton J, Reddel HK, Hancox RJ, Harwood M, Corin A, Sparks J, Hall D, Sabbagh D, Mane S, Vohlidkova A, Martindale J, Williams M, Shirtcliffe P, Holliday M, Weatherall M, Beasley R; PRACTICAL study team. Hardy J, et al. Among authors: shirtcliffe p. Lancet. 2019 Sep 14;394(10202):919-928. doi: 10.1016/S0140-6736(19)31948-8. Epub 2019 Aug 23. Lancet. 2019. PMID: 31451207 Clinical Trial.
The β-2 agonist debate: is there still a problem?
Patel M, Shirtcliffe P, Beasley R. Patel M, et al. Among authors: shirtcliffe p. Curr Opin Allergy Clin Immunol. 2013 Feb;13(1):58-62. doi: 10.1097/ACI.0b013e32835a5ad9. Curr Opin Allergy Clin Immunol. 2013. PMID: 23037719 Review.
Time to define the disorders of the syndrome of COPD.
Beasley R, Weatherall M, Travers J, Shirtcliffe P. Beasley R, et al. Among authors: shirtcliffe p. Lancet. 2009 Aug 29;374(9691):670-2. doi: 10.1016/S0140-6736(09)61541-5. Lancet. 2009. PMID: 19716947 Review. No abstract available.
53 results